SCHEMBL19784018

SCHEMBL19784018

O=C(N[C@@H](CCl)C(F)(F)F)c1cn(-c2ncc(F)cc2F)c2nc(Cl)ccc2c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.33
KCNH2 Q12809 4/20 0.33
MAPK8 P45983 1/20 0.32
EPHA2 P29317 1/20 0.32
FLT4 P35916 1/20 0.32
GSK3B P49841 1/20 0.32
RARB P10826 1/20 0.32
TBXAS1 P24557 1/20 0.32
SLC6A3 Q01959 1/20 0.32
SLC22A2 O15244 1/20 0.32
KMT2A Q03164 4/20 0.31
LMNA P02545 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
HPGD P15428 1/20 0.31
XBP1 P17861 1/20 0.31
NFKB1 P19838 1/20 0.31
HTT P42858 1/20 0.31
NFKB2 Q00653 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19784013 0.92 GSK3B (0.35) PDE4AKCNH2MAPK8EPHA2FLT4
SCHEMBL20969353 0.92 GSK3B (0.35) PDE4AKCNH2MAPK8EPHA2FLT4
SCHEMBL19784014 0.92 GSK3B (0.35) PDE4AKCNH2MAPK8EPHA2FLT4
SCHEMBL19784041 0.90 PDE4A (0.34) PDE4AKCNH2MAPK8EPHA2FLT4
SCHEMBL21220030 0.88 ALOX5AP (0.37) PDE4AKCNH2GSK3B
SCHEMBL19783488 0.88 ALOX5AP (0.37) PDE4AKCNH2GSK3B
SCHEMBL19784020 0.88 PDE4A (0.37) PDE4AKCNH2MAPK8EPHA2FLT4
SCHEMBL20969339 0.88 KMT2A (0.33) PDE4AKCNH2MAPK8EPHA2FLT4
SCHEMBL19783902 0.88 KMT2A (0.33) PDE4AKCNH2MAPK8EPHA2FLT4
SCHEMBL20969297 0.86 PDE4A (0.34) PDE4AKCNH2EPHA2FLT4GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018011017-A1 7-SUBSTITUTED 1-PYRIDYL-NAPHTHYRIDINE-3-CARBOXYLIC ACID AMIDES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-01-18 WO disclosed